A Brief Review of Pharmacokinetic Assessments of Vancomycin in Special Groups of Patients with Altered Pharmacokinetic Parameters.

Ghasemiyeh, Parisa; Vazin, Afsaneh; Mohammadi-Samani, Soliman

Ghasemiyeh, Parisa; Vazin, Afsaneh; Mohammadi-Samani, Soliman.

Afiliación

Ghasemiyeh P; Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Vazin A; Pharmaceutical Sciences Research Center, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammadi-Samani S; Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Curr Drug Saf ; 18(4): 425-439, 2023.

Article en En | MEDLINE | ID: mdl-35927907

Asunto(s)

Antibacterianos; Monitoreo de Drogas; Vancomicina; Vancomicina/farmacocinética; Antibacterianos/farmacocinética; Obesidad Mórbida; Humanos; Infecciones por Bacterias Grampositivas

Palabras clave

Vancomycin; acute kidney injury (AKI); altered pharmacokinetics; antibiotic; individualized pharmacotherapy; therapeutic drug monitoring (TDM)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vancomicina / Monitoreo de Drogas / Antibacterianos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Curr Drug Saf Año: 2023 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google